Infective Endocarditis: Evidence‑Based Diagnostic and Management Guidelines

1. Recognizable Peripheral Stigmata

• Janeway lesions – painless erythematous macules on the palms and soles that reflect septic emboli and are classified as vascular phenomena in the Modified Duke criteria. CDC recommendation. 1
• Osler nodes – painful, tender purple nodules on fingertips or toes representing immunologic phenomena. CDC recommendation. 1
• Roth spots – retinal hemorrhages with pale centers, also an immunologic phenomenon. CDC recommendation. 1

2. Diagnostic Work‑up

2.1 Blood Cultures

• Obtain ≥ 3 separate sets of blood cultures from different venipuncture sites before any antimicrobial therapy. This is a Class I recommendation with Level C evidence from the American College of Cardiology. 2
• Draw cultures > 12 h apart when feasible, or ensure the first and last samples are at least 1 h apart. CDC recommendation. 1
• Critical pitfall: initiating antibiotics before adequate cultures can render them negative and obscure the diagnosis. European Society of Cardiology warning. 3

2.2 Echocardiography

• Transthoracic echocardiography (TTE) should be performed immediately as the first‑line imaging study. American College of Cardiology and European Society of Cardiology guidance. [2][3]4
• TTE sensitivity: detects vegetations in 60–75 % of IE cases. American College of Cardiology data. 2
• If TTE is negative but clinical suspicion remains high, proceed without delay to transesophageal echocardiography (TEE), which has > 95 % sensitivity for vegetations. American College of Cardiology and European Society of Cardiology guidance. [2][3]4
• TEE is specifically recommended for patients with prosthetic valves, prior IE, or suspected complications (e.g., paravalvular abscess). American College of Cardiology and European Society of Cardiology guidance. [2][3]
• Repeat echocardiography within 7–10 days if the initial study is negative but suspicion persists. European Society of Cardiology recommendation. 3

2.3 Supportive Laboratory Findings

• Elevated inflammatory markers (C‑reactive protein, erythrocyte sedimentation rate) support the diagnosis. European Society of Cardiology observation. 4
• Microscopic hematuria suggesting glomerulonephritis adds diagnostic weight. American College of Cardiology observation. 2

3. Application of the Modified Duke Criteria

• Definite IE requires (i) two major criteria, or (ii) one major + three minor, or (iii) five minor criteria. CDC definition. 1

3.1 Major Criteria

3.2 Minor Criteria

• Predisposing heart condition or intravenous drug use – CDC 1
• Fever > 38 °C – CDC 1
• Vascular phenomena – major arterial emboli, septic pulmonary infarcts, mycotic aneurysm, intracranial hemorrhage, conjunctival hemorrhages, Janeway lesions – CDC and European Society of Cardiology [1][3]
• Immunologic phenomena – glomerulonephritis, Osler nodes, Roth spots, rheumatoid factor – CDC and European Society of Cardiology [1][3]

4. Initial Management

4.1 Empiric Antimicrobial Therapy

• After cultures are drawn, initiate empiric antibiotics promptly when clinical suspicion is high. (Evidence level not specified in cited sources.)
• Causative spectrum: Streptococci and staphylococci together account for ≈ 80 % of IE cases. American College of Cardiology data. 2
• S. aureus is responsible for ≈ 80 % of tricuspid‑valve infections, especially in IV drug users. American College of Cardiology data. 2

4.2 Multidisciplinary “Endocarditis Team”

• Immediate involvement of cardiology and infectious‑disease specialists is advised. European Society of Cardiology recommendation. [3][4]
• Team composition for complicated IE includes:
  
  • Infectious‑disease physician – European Society of Cardiology 4
  • Cardiologist – European Society of Cardiology 4
  • Cardiac surgeon – European Society of Cardiology 4
  • Microbiologist – European Society of Cardiology 4
  • Imaging specialist – European Society of Cardiology 4

5. Populations Requiring Heightened Suspicion

• Prosthetic heart valves – American College of Cardiology and European Society of Cardiology guidance. [2][3]4
• Congenital heart disease – European Society of Cardiology guidance. [3][4]
• Intracardiac devices (pacemakers, defibrillators) – European Society of Cardiology guidance. 3

6. Common Pitfalls and Safety Checks

• Never start antibiotics before obtaining adequate blood cultures – European Society of Cardiology warning. 3
• Do not dismiss IE solely because peripheral stigmata are absent; their absence is common in modern practice. European Society of Cardiology observation. 4
• Do not rely exclusively on TTE; proceed to TEE when suspicion remains high despite a negative TTE. American College of Cardiology and European Society of Cardiology guidance. [2][3]4
• Transfer patients with complicated IE to specialized “Endocarditis Team” centers to improve outcomes. European Society of Cardiology recommendation. 4

Diagnosis and Management of Infective Endocarditis

Clinical Presentation and Diagnosis

• The American College of Cardiology and the American Heart Association recommend that the presence of Janeway lesions should immediately trigger suspicion of infective endocarditis (IE), especially when accompanied by fever lasting more than 48 hours, cardiac murmur suggestive of valvular or congenital heart disease, and other physical findings such as petechiae, Osler's nodes, Roth spots, splenomegaly, or splinter hemorrhages 5, 6, 7
• Patients with predisposing factors, including prosthetic heart valves, congenital heart disease, and history of intravenous drug use, are at higher risk of developing IE 8, 7, 9
• The American Heart Association recommends obtaining at least 2-3 sets of blood cultures from different venipuncture sites before starting antibiotics, with a Class I recommendation for patients with unexplained fever for more than 48 hours who are at risk for IE 5, 6
• The American College of Cardiology recommends performing echocardiography, including transthoracic echocardiography (TTE) as first-line imaging and transesophageal echocardiography (TEE) if TTE is negative but clinical suspicion remains high, to diagnose IE 6, 8

Treatment and Management

• The American Heart Association recommends that once blood cultures are obtained, empiric antimicrobial therapy should be initiated if clinical suspicion of IE is high, with therapy tailored based on the identified pathogen 6, 8
• The American College of Cardiology recommends that the duration of therapy typically ranges from 4-6 weeks depending on the pathogen and presence of complications, with a Class III recommendation against administering antibiotics before obtaining blood cultures in patients with known valve disease or valve prosthesis who present with unexplained fever 5, 6
• The American Heart Association recommends early surgical consultation for all complicated IE cases, including those with heart failure due to valvular destruction, uncontrolled infection, prevention of embolic events, and large vegetation size 8
• The American College of Cardiology recommends management by an "Endocarditis Team" at a reference center for complicated cases, including cardiologists, infectious disease specialists, cardiac surgeons, and anesthesiologists 8